Waters Corporation (WAT) on Wednesday said the BD BACTEC FXI Culture System has received U.S. Food and Drug Administration 510(k) clearance.
The BD BACTEC FXI Culture System is a next-generation, fully automated blood culture system designed to improve the speed, consistency, and accuracy of bloodstream infection diagnostics.
The company said the system automates vial loading, unloading, incubation, and detection alerts, and can load up to 60 vials at a time, 50% more than the leading competing system. Clinical study data showed that the BD BACTEC FXI Culture System reduced the mean time to detection by about three hours compared with the previous-generation BD BACTEC FX Blood Culture System.
Waters Corp. shares closed at $371.93 on Tuesday, down 1.65%
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.